Latest IPO Information

Curis Lifesciences Ltd. IPO

IPO Date: Nov 7 to Nov 11 2025

Listing Date: Nov 14 2025

Objective

i.Capital Expenditure towards Upgradation/Improvement of our existing Manufacturing Facilities;ii.Capital Expenditure towards Construction of a Storage Facility;iii.Pre-payment/Repayment of outstanding Secured Loans;iv.Product Registrations in other countries;v.Funding our Working Capital Requirements; andvi.General Corporate Purpose.

IPO Details

Face Value ₹ 10.00 Per Share
Issue Size ₹ 18.49 - 19.72 Cr
Price Band ₹ 120.00 - ₹ 128.00 Per Share
Market LOT 2000 shares
Issue Type Book building

About Company

Our business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic onloan license or contract Manufacturing and own brand marketing basis. Our business is majorly on principle to principlebasis with different marketers. As on the date of this Draft Red Herring Prospectus, we cater to more than 100 corporateclients on loan license and/or contract manufacturing basis along with 2 clients for own brand marketing globally ofRepublic of Yemen and Kenya. Our company has commenced manufacturing facility in year 2017, hence, our companyhas experience .... of more than 5 years in the current line of business of the company. as on the date of this Draft Red HerringProspectus our manufacturing facility at Curis Lifesciences Limited is installed with capacity to manufacture 138 Croretables / year, 15.75 Crore Capsules / year, 1080 Kilolitre Oral Liquid/ year, 270 Tons external preparation / year and 45Tons sterile ophthalmic ointment / year. Our promoters have a vast experience in the pharmaceutical manufacturingIndustry. Driven by the passion for building an integrated pharmaceutical company, backed by their experience, ourPromoters have been the pillars of our Company's growth and have built a strong value system for our Company. Withtheir enriching experience and progressive thinking, we aim to continue to grow in the pharmaceutical industry Read More
Address

P F-23, G I D C Sanand - I I Industrial Estate, Sanand

City

Ahmedabad

State

Gujarat

Pincode

382110

Phone

7096558558

Email

info@curisls.com

Website

www.curisls.com

About IPO

Listed At NSE
Lead Manager Finaax Capital Advisors Pvt Ltd
Promoters
Dharmesh Dashrathbhai Patel
Siddhant Jayantibhai Pawasia
Piyush Gordhanbhai Antala
Jaimik Mansukhbhai Patel

Promoter's Holding

Registrar

MUFG Intime India Pvt Ltd.

+91 810 811 8484
rnt.helpdesk@in.mpms.mufg.com
https://in.mpms.mufg.com/

Latest News

Oct
27
2026
EQUITY Posted on Oct 27th 2026

APL Apollo Tubes informs about newspaper publication

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, APL Apollo Tubes has enclosed copies of the newspaper advertisements published in the ‘The Economic Times & Financial Express’ (English) and ‘Jansatta & Navbharat Times’ (Hindi) on October 27, 2026 with respect to the Unaudited Financial Results for the quarter and half year ended September 30, 2026. The advertisement also includes a Quick Response code and the weblink to access complete financial results for the said period. The above information is being uploaded on the website of the Company at www.aplapollo.com.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
27
2026
EQUITY Posted on Oct 27th 2026

Wealth First Portfolio Managers informs about newspaper publication

Pursuant to Regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, Wealth First Portfolio Managers has submitted the copies of Public Notice published in newspapers of Ahmedabad edition viz. Financial Express (English) Page No. 30 and Financial Express (Regional Language) Page No. 7 on 27th October, 2026 in compliance with Ministry of Corporate Affairs Circular No. 20/2020 dated May 05, 2020, with respect to the 1stExtra-Ordinary General Meeting of the members of the Company scheduled to be held on Saturday 21st November, 2026 at 02.00 PM IST through Video Conferencing (VC) / Other Audio Visual Means (OAVM). 
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
27
2026
EQUITY Posted on Oct 27th 2026

Cyber Media India informs about newspaper publication

Pursuant to Regulation 30 read with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cyber Media India has enclosed copies of newspaper advertisements published in ‘Financial Express’-English Edition and ‘Jansatta’-Hindi Edition, both dated October 27, 2026, with respect to approval of the unaudited financial results, standalone and consolidated, of the Company for the quarter and half year ended September 30, 2026. The advertisement copies are also available on the Company’s website at www.cybermedia.co.in.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
27
2026
EQUITY Posted on Oct 27th 2026

Zenith Fibres submit board meeting intimation

Zenith Fibres has informed that pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, a meeting of the Board of Directors of Zenith Fibres (the Company) is scheduled to be held on Wednesday, November 04, 2026, to consider and approve the Unaudited Financial Results of the Company for the Second Quarter and Half year ended September 30, 2026 of the current financial year 2026-27. Further, in continuation of letter dated September 23, 2026, for the aforesaid purpose, the Trading Window for buying, selling, pledging, dealing, trading etc. in the securities of the Company has been closed from Thursday, October 01, 2026 and will continue to remain closed till the completion of 48 hours after the declaration/publication of the Unaudited Financial Results of the Company for the Second Quarter and Half year ended September 30, 2026, of the current financial year 2026-27, i.e., Friday, November 06, 2026, as required under the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended. The above information is also being made available on the Company's website at www.zenithfibres.com.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
27
2026
EQUITY Posted on Oct 27th 2026

Bharat Forge submits board meeting intimation

Bharat Forge has informed that pursuant to Regulation 29 and Regulation 50(1) of the Listing Regulations, the meeting of the Board of Directors of Bharat Forge is scheduled to be held on Thursday, November 5, 2026, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026. Further, referring to our communication dated September 28, 2026, and pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s Code of Conduct for Prevention of Insider Trading, the trading window for all Directors and Designated Persons and their immediate relatives and specified Connected Persons has been kept closed for dealing in the securities of the Company with effect from October 01, 2026. This is to further inform that the trading window shall be re-opened for the aforesaid persons from Monday, November 9, 2026, to deal in the securities of the Company.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the issue size of Curis Lifesciences Ltd. IPO?

The issue size of Curis Lifesciences Ltd. IPO is ₹18.49 - 19.72 crore.

The Curis Lifesciences Ltd. IPO opens for subscription on 2025-11-07 and closes on 2025-11-11.

The price range of Curis Lifesciences Ltd. IPO is ₹120.00 to ₹128.00.

The lot size of Curis Lifesciences Ltd. IPO is 2000 shares.

The registrar of Curis Lifesciences Ltd. IPO is MUFG Intime India Pvt Ltd..

Curis Lifesciences Ltd. IPO will be listed on NSE .

You will typically receive a confirmation message or notification from your broker or trading platform shortly after placing your IPO order. This confirms that your application has been submitted successfully. You can also check the order status in the IPO section of your trading account or app.

Apply early with valid UPI and PAN before 2025-11-11 to increase your chances.

The listing date of Curis Lifesciences Ltd. IPO is 2025-11-14.

An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.

Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.

The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.

Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.

The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:

Past Financial Performance: Evaluating the company's revenue, profits, and financial stability over time

Growth Potential: Assessing future prospects based on the company's business model and market opportunities

Industry Peers: Comparing valuation metrics with similar companies in the same sector

Larger Industry Picture: Analysing overall industry trends and economic conditions that could impact the company's performance

The lock-in period for IPO shares refers to a duration during which specific investors are restricted from selling their shares post-listing. This period varies based on the type of investor:

Promoters: The lock-in period for promoters ranges from 6 months to 18 months, ensuring their commitment to the company's long-term growth

Anchor Investors: Typically, anchor investors face a shorter lock-in period of 30 to 90 days, depending on regulatory norms and the specific IPO

IPOs can be volatile and may not perform as expected in the short term. Investors risk losing capital if the stock price drops after listing, especially if the company does not meet its growth projections.

Information on upcoming IPOs is often available through brokerage platforms, financial news sites, and regulatory bodies like SEBI, which publishes details on companies going public. You can also get these details under the upcoming IPO section on Bajaj Markets.

Eligibility for an IPO typically includes:

Retail Investors: Individuals who invest in smaller amounts, usually under the “retail investor” category, with certain limits

Qualified Institutional Buyers (QIBs): Entities like mutual funds, banks, and insurance companies, who invest large sums

Non-Institutional Investors (NIIs): High-net-worth individuals or entities investing above the retail threshold

Investors must have a Demat and trading account to apply, and in some cases, certain financial or residency qualifications may apply depending on local regulations.

SME (Small and Medium Enterprise) IPOs generally carry higher risk but may provide significant growth potential. Investors should research the company’s stability, financials, and sector risks, as SME stocks can be more volatile compared to large-cap companies.

View More

Invalid Mobile Number

Invalid Full Name

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore